1. Potential role of “omics” technique in prenatal diagnosis of congenital heart defects
    Lizhu Chen et al, 2018, Clinica Chimica Acta CrossRef
  2. At the heart of programming: the role of micro-RNAs
    B. Siddeek et al, 2018, J Dev Orig Health Dis CrossRef
  3. miR-20a regulates proliferation, differentiation and apoptosis in P19 cell model of cardiac differentiation by targeting Smoothened
    Feng Ai et al, 2016, Biology Open CrossRef
  4. SPERM EPIGENOME AS A MARKER OF ENVIRONMENTAL EXPOSURE AND LIFESTYLE, AT THE ORIGIN OF DISEASES INHERITANCE
    Benazir Siddeek et al, 2018, Mutation Research/Reviews in Mutation Research CrossRef
  5. Noninvasive prenatal testing for congenital heart disease – cell-free nucleic acid and protein biomarkers in maternal blood
    Orsolya Biró et al, 2018, The Journal of Maternal-Fetal & Neonatal Medicine CrossRef
  6. What people with Down Syndrome can teach us about cardiopulmonary disease
    Kelley L. Colvin et al, 2017, Eur Respir Rev CrossRef
  7. Genome-Wide DNA Methylation Analysis and Epigenetic Variations Associated with Congenital Aortic Valve Stenosis (AVS)
    Uppala Radhakrishna et al, 2016, PLoS ONE CrossRef
  8. Mature miR-99a Upregulation in the Amniotic Fluid Samples from Female Fetus Down Syndrome Pregnancies: A Pilot Study
    Anda-Cornelia Vizitiu et al, 2019, Medicina CrossRef
  9. Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine
    Beenish Rahat et al, 2020, Front. Genet. CrossRef
  10. Non-Coding RNAs as Blood-Based Biomarkers in Cardiovascular Disease
    Raquel Figuinha Videira et al, 2020, IJMS CrossRef
  11. Alterations of epigenetic landscape in Down syndrome carrying pregnancies: a systematic review of case-control studies
    Mohammad Reza Karimzadeh et al, 2021, European Journal of Obstetrics & Gynecology and Reproductive Biology CrossRef